Similarly, anti-obesity and antidiabetic drug liraglutide, a GLP-1 analogue, reduced Tau phosphorylation and enhanced memory and learning in various models exhibiting AD pathology (Holubová et al. 2019; McClean & Holscher 2014; McClean et al. 2015; Spolcova et al. 2015). Here, MAPT is linked to Alzheimer disease.